Michael Buschle
12Patents
7h-index
21Co-inventors
62Inventor score
Filing activity: Feb 21, 1997 → May 18, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6869607B1 | Vaccine formulations | Human Necessities | 54 | Expired |
| US7148191B2 | Antigenic composition | Chemistry; Metallurgy | 38 | Expired |
| US5965404A | Method for introducing nucleic acids into higher eukaryotic cells | Human Necessities | 15 | Expired |
| US7105162B1 | Pharmaceutical composition for immunomodulation based on peptides and adjuvants | Chemistry; Metallurgy | 13 | Expired |
| US7704514B2 | Vaccines | Emerging Cross-Sectional Technologies | 9 | Expired |
| US7378234B2 | Method for isolating hepatitis C virus peptides | Emerging Cross-Sectional Technologies | 8 | Expired |
| US7244438B2 | Uses for polycationic compounds | Human Necessities | 7 | Expired |
| US8784837B2 | Vaccines comprising an immunostimulatory peptide and an immunostimulatory oligodeoxynucleic acid molecule | Emerging Cross-Sectional Technologies | 5 | Active |
| US8277815B2 | Pharmaceutical composition comprising an antigen | Chemistry; Metallurgy | 3 | Active |
| US8361476B2 | Vaccine composition comprising an antigen and a peptide having adjuvant properties | Emerging Cross-Sectional Technologies | 2 | Active |
| US7658928B2 | Method of vaccination comprising administering an antigen and a cathelicidin derived antimicrobial peptide | Human Necessities | 2 | Active |
| US8900564B2 | Vaccine composition comprising an antigen and a peptide having adjuvant properties | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.